skip to the content

Clinical Trials

Opiod Analgesic Depression Study

A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opiod Analgesic Depression

Protocol ID

06.04.109T

Protocol Description

The purpose of this study is to identify an effective treatment program for patients dependent on prescription opioids. By prescription opioids we mean medications including but not limited to Percocet, OxyContin, Vicodin, and Morphine. In this two-phase study, all subjects will receive the medication buprenorphine/naloxone (BUP/NX) also known commercially as Suboxone. Both phases will look at the effect of treatment with BUPNX plus either standard medical management (SMM) or enhanced medical management (EMM).

Eligibility Criteria

Patients who are 18 years old or older, dependent on prescription opioids, and seeking treatment with a desire to stop opioid use

Primary Investigator(s)

  • Jeffrey Selzer, MD

Contact Information

Megan Ghiroli
(718) 470-8893
ghiroli@yahoo.com

Last Update

March 25, 2010
top
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Addiction:
top
top